Karuna Therapeutics, Inc. Operating Income (Loss) in USD from Q2 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Karuna Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2018 to Q4 2023.
  • Karuna Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2023 was -$130M, a 52.4% decline year-over-year.
  • Karuna Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2023 was -$495M, a 70.8% decline year-over-year.
  • Karuna Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$495M, a 70.8% decline from 2022.
  • Karuna Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$290M, a 101% decline from 2021.
  • Karuna Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$144M, a 100% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)

Karuna Therapeutics, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$495M -$130M -$44.6M -52.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 -$450M -$136M -$55.2M -68.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$395M -$120M -$54.9M -84.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 -$340M -$109M -$50.5M -86.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-04
Q4 2022 -$290M -$85M -$56.8M -202% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 -$233M -$81M -$29.8M -58.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$203M -$65.1M -$30.5M -88.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$172M -$58.6M -$28.6M -95.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$144M -$28.2M -$3.78M -15.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 -$140M -$51.2M -$31.6M -162% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$108M -$34.5M -$16.7M -93.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$91.7M -$30M -$19.9M -198% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$71.8M -$24.4M -$15.5M -175% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 -$56.3M -$19.5M -$9.63M -97.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$46.6M -$17.8M -$2.76M -18.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$43.9M -$10.1M +$1.52M +13.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$45.4M -$8.87M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 -$9.9M -$7.42M -300% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$15.1M -$12.6M -520% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$11.6M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q3 2018 -$2.47M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$2.43M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08

Karuna Therapeutics, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$495M -$205M -70.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 -$290M -$146M -101% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 -$144M -$72M -100% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 -$71.8M -$26.4M -58.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 -$45.4M -$30.9M -213% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$14.5M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.